A total of eleven institutions have joined forces, and set up an EU project
“Marine Fungi” in order to evaluate the therapeutic potential of marine fungi
as anti-cancer drugs. VTT Technical Research Centre of Finland will primarily
be involved in the development of robust, sustainable production conditions in
Marine organisms are an important resource of natural products, used for
example in cosmetics and agriculture, but also as therapeutics for the
treatment of human diseases. Marine fungi, a group of organisms which have so
far remained unexploited, are the focus resource in the new “Marine Fungi”
The aim of the project is to evaluate the
therapeutic potential of natural products of known strains and new isolates of
unique habitats in particular fungi inhabiting tropical coral reefs,
macroalgae of the Pacific Ocean and Mediterranean sponges as anti-cancer
The project also strives for development of a
sustainable, large-scale production of these natural marine products in a
laboratory thus avoiding harm to the natural environment through harvesting.
The project also aims to see some marine natural products progress to an in
vivo proof of concept stage.
The project started in May 2011
and lasts for 3 years. Total project budget: 3 Million euros.
partners: Leibniz institute für Meeresvissenschaften and der Universität Kiel
(IFM-GEOMAR, coordinating the project) Hypha Discovery Limited (UK), Aarhus
University (Denmark), Christian Albrects University in Kiel (Germany), Danish
Technological Institute, University of Diponegoro (Indonesia) University of
Antofagasta (Chile), European Screeningport Gmbh (Germany), Probiodrug Ag.
(Germany) and University of Oslo (Norway).